comparemela.com

Latest Breaking News On - தாமஸ் ஜாகோப்சன் - Page 2 : comparemela.com

With two new appointments from Gov Spencer Cox, the DABC liquor commission could become majority female

Women may soon be the majority on the Utah alcohol commission Gov. Cox appoints Jennifer Tarazon, a communication director for AARP Utah, and Natalie Randall, a state tourism director, to the DABC board. (Rick Egan | The Salt Lake Tribune) Customers line up for the opening of the new state liquor and wine store in Saratoga Springs, on Monday, Nov. 16, 2020.   | April 23, 2021, 7:06 p.m. On Friday, Gov. Spencer Cox named two women to the sometimes controversial board that oversees liquor sales and licensing in Utah. That is likely a first for the high-profile board. Increasing diversity on Utah’s boards and commission is a key part of the 500-day plan of the Cox-Henderson administration, according to a news release announcing appointments for more than four dozen state boards and commissions, including the DABC.

DABC will be majority women after Utah s governor shakes up boards and commissions

DABC will be majority women after Utah s governor shakes up boards and commissions Utah Dept. of Alcoholic Beverage Control Governor Spencer Cox visits the Utah Department of Alcoholic Beverage Control s massive warehouse as a part of a review of the state s liquor control agency. and last updated 2021-04-23 13:25:26-04 SALT LAKE CITY — Utah s Department of Alcoholic Beverage Control Commission will be led by a majority of women under a shakeup proposed by Governor Spencer Cox. It s part of a push to increase diversity and inclusion in all of Utah s boards and commissions, the governor s office said. On Friday, his office released a list of dozens of names for boards and commissions which help decide policy for the state.

Hyloris Pharmaceuticals: Hyloris Reports Full Year 2020 Financial Results

Hyloris Pharmaceuticals: Hyloris Reports Full Year 2020 Financial Results On track to fuel the pipeline with =4 new product candidates in 2021 Strong cash position of €64 million year-end to execute ambitious growth plan 14 commercial products expected by 2024 Conference call and Liège, Belgium - 9 March 2021 - Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populations, today reports its consolidated financial results and a business update for the year ended 31 December 2020, recent achievements, and an outlook for 2021. Stijn Van Rompay, Chief Executive Officer of Hyloris, commented: I am extremely proud of the significant progress we have made across all areas of our business, which has set a strong foundation to execute our ambitious growth plan. We are committed to changing the lives of patients by applying our knowhow and innovative technol

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.